Racura Oncology opens Korean recruitment for RC220 Phase 1 trial
Racura Oncology opened Korean recruitment for RC220, a Phase 1 solid tumours trial.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Racura Oncology opened Korean recruitment for RC220, a Phase 1 solid tumours trial.